Granisetron insulin receptor isoform A and insulin

Pirritt C, Sun Y, Yao Y et al (009) Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor. Future Med Chem (6):53–7 . Hopkins A, Crowe PJ, Yang JL (00) Effect of type insulin- like growth factor receptor granisetron targeted therapy on chemotherapy in human cancer and the mechanisms involved. J Cancer Res Clin Oncol 36(5):639–650 3. Pierce LJ, Hutchins LF, Green SR, Lew DL, Gralow JR, Liv- ingston RB, Osborne CK, Albain KS (005) Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.

J Clin Oncol 3():4–9 4. Abuharbeid S, Apel J, Zugmaier G, Knabbe C, Sander M, Gilbert S, Czubayko F, Aigner A (005) Inhibition of HER- by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells. Naunyn Cladribine Schmiedebergs Arch Pharmacol 37():4–5 5. Zeng X, Sachdev D, Zhang H, Gaillard-Kelly M, Yee D (009) Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo. Clin Cancer Res 5(8):840–849 0. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD (007) MDA-MB-435 cells are derived from M4 melanoma cells—a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 04():3–9 .

Leonessa F, Green D, Licht T, Wright A, Wingate-Legette K, Lippman J, Gottesman MM, Clarke R (996) MDA435/LCC6 and MDA435/LCC6MDR: ascites models of human breast cancer. Br J Cancer 73():54–6 . Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, Yee D (00) Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene 9(7):57– 57 3. Sachdev D, Zhang X, Matise I, Gaillard-Kelly M, Yee D (00) The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene 9():5–6 4. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kim DH, Kundu M (009) ULK-Atg3-FIP00 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 0(7): 99–003 5. Mizushima N, Yoshimori T (007) How to interpret LC3 immunoblotting. Autophagy 3(6):54–545 6. Wahner Hendrickson AE.

Haluska P, Schneider PA, Loegering DA, Peterson KL, Attar R, Smith BD, Erlichman C, Gottardis M, Karp JE et al (009) Expression of insulin receptor isoform A and insulin-like growth factor- receptor in human acute myeloge- nous leukemia: effect of the foodborne illness dual-receptor inhibitor BMS-53694 in vitro. Cancer Res 69(9):7635–7643 7. Chen YW, Boyartchuk V, Lewis BC (009) Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. Neoplasia (9):835–845 8. Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A et al (009) Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res 69(6):443–45 9. Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, Tao N, Rosenfeld-Franklin M, Lerner L, Chiu MI, Wild R et al (00) Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor- receptor (IGF-R): rationale for co- targeting IGF-R and IR in cancer. Mol Cancer Ther 9(0):65–664 30. Ulanet DB, Ludwig DL, Kahn CR, Hanahan D (00) Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-R targeted therapy. Proc Natl Acad Sci USA 07(4):079–0798 3. Wang RC, Levine B (00) Autophagy in cellular growth control. FEBS Lett 584(7):47–46 3. Pimkina J, Murphy ME (009) ARF, autophagy and tumor sup- pression. Autophagy 5(3):397–399 33. Levine B, Kroemer G (008) Autophagy in the pathogenesis of disease. Cell 3():7–4 34. Li X, Fan Z (00) The epidermal growth factor receptor anti- body cetuximab induces autophagy in cancer cells by 3 9 Published OnlineFirst December 9, 0; DOI:0.58/535-763.MCT–037 Molecular Medicine in Practice Mo

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>